ISRWF:OTC-iShares II Public Limited Company - iShares J.P. Morgan $ Emerging Markets Bond UCITS ETF (USD)

ETF | Others |

Last Closing

USD 85.657

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

+4.08 (+0.71%)

USD 32.85B
ZKBGF ZKB Gold ETF

+132.73 (+4.63%)

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
CRSLF CRSLF

N/A

USD 7.64B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
BAWAY BAWAY

N/A

USD 7.32B
EBCRY EBCRY

N/A

USD 3.32B
SSEEF SSgA SPDR ETFs Europe I Public..

N/A

USD 2.95B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B

ETFs Containing ISRWF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -0.84% 32% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.84% 29% F 55% F
Trailing 5 Years  
Capital Gain -12.89% 19% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.89% 15% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain -5.92% N/A N/A N/A N/A
Dividend Return -4.23% N/A N/A N/A N/A
Total Return 1.70% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.42% N/A N/A N/A N/A
Risk Adjusted Return -34.02% N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike